Navigation Links
Empire Genomics Chooses Funakoshi as Japan Distributor

BUFFALO, N.Y., April 24, 2012 /PRNewswire-iReach/ -- Empire Genomics today announced that it has chosen Funakoshi as a distributor of its product portfolio for the Japanese market.  The deal represents Empire's international expansion and importance of growth in the region.

"We are excited to have such a proven and expert partner in Funakoshi to service our Japanese customers and offer access to our broad genomic product and service portfolio," said Anthony Johnson, President and CEO of Empire Genomics. "I am confident this relationship will provide customers with the excellent support and high quality service  our customers have come to expect."   

"We are delighted with Empire Genomics agreement. Empire Genomics perfectly complements our portfolio range of high quality products and services. Empire Genomics portfolio provides Funakoshi Company the opportunity to meet high demands for basic bioscience research and also for the pharmaceutical research in Japan." said Dr.Ryoya Funakoshi, President & CEO of Funakoshi Company, Ltd.

Financial terms of the deal were not disclosed.

About Empire Genomics, LLC

Empire Genomics delivers the most advanced genomic tools to aid the scientific community in its research and diagnostic challenges. Through many years of experience in the area of  genomics and working with diverse sample types, we are able to provide continuous innovation for research and diagnostic applications in areas of oncology, biomarkers, drug discovery, constitutional disorders, developmental disorders and autism, among many others.

About Funakoshi Co. Ltd.

Funakoshi Co., Ltd. has contributed as a leader to distribute research reagents and instruments for researchers in life science fields since its foundation. The mission of Funakoshi is offering many useful tools with leading edge technologies for Japanese researchers from all over the world to support and develop their research. For more information, visit Funakoshi's website:

Media Contact:

Sonya Stutts Empire Genomics, LLC, 716-856-3873,

News distributed by PR Newswire iReach:

SOURCE Empire Genomics, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Research Alert -- Empire Asset Management Co. Initiates Coverage on Pacira Pharmaceuticals Inc. (NASDAQ: PCRX)
2. Empire BlueCross BlueShield Expands Lab Networks -- Creating Broader Choice, Robust Competition and Lower Costs for Consumers
3. CrystalGenomics Announces Positive Results from Phase 2b Osteoarthritis Study of CG100649
4. Everist Genomics Develops Worlds First Comprehensive Companion Diagnostics and Prognostics Portfolio for Early Diagnosis and Improved Treatment of Colorectal Cancer
5. Rubicon Genomics Selects Velesco to Manufacture its TransPLEX® RNA Amplification Kits for Clinical Diagnostic Use
6. Compendia Bioscience and H3 Biomedicine Announce Strategic Collaboration to Apply Cancer Genomics to Discover and Develop Next Generation Cancer Therapeutics
7. Synthetic Genomics, Inc. and Integrated DNA Technologies, Inc. Sign Agreement to Manufacture, Market, and Commercialize Small Synthetic Gene Products Using SGI Technology
8. Smartphone Technology Meets Personalized Medicine in Everist Genomics CardioDefender Diagnostic System
9. AccuGenomics to Attend OneMedForum with Standardized Gene Expression Tests for Leukemia and Lung Cancer
10. AbGenomics International, Inc. Regains Global Rights to AbGn-168H from Boehringer Ingelheim
11. Everist Genomics to Launch CardioDefender: Worlds Only Mobile ECG System that Delivers Real-time, Beat-by-beat, Quantitative Heart Monitoring Data to Physicians
Post Your Comments:
(Date:10/13/2015)... YORK , Oct. 13, 2015 Pomerantz ... filed against Amicus Therapeutics, Inc. ("Amicus" or the "Company")(NASDAQ: ... filed in United States District Court, District of ... a class consisting of all persons or entities who ... 1, 2015 inclusive (the "Class Period"). This class action seeks ...
(Date:10/13/2015)... BOSTON , Oct. 13, 2015 ... lawsuits against GlaxoSmithKline (GSK) related to the pharmaceutical ... defects alleged to have been caused by their ... profile of this drug for pregnant women.   Due ... lawsuits against GSK, The United States Judicial Panel ...
(Date:10/13/2015)... Oct. 13, 2015 VIVA Physicians, a not-for-profit ... and intervention through education and research, is excited to ... 2015 . Sixteen trial results, featuring the latest in ... first time on Monday and Tuesday, November 2 and ... --> --> Since 2003, VIVA Physicians ...
Breaking Medicine Technology:
(Date:10/13/2015)... ... October 13, 2015 , ... Relay ... messaging application, announced today a significant contract that will provide its award-winning private ... to build on the growing success of its Relay program, IBX Wire™, which ...
(Date:10/13/2015)... ST. LOUIS and CHENNAI, India (PRWEB) , ... October 13, 2015 ... ... the development of advanced camera solutions, today announced See3CAM_CU40, the industry’s first ... stand-alone MIPI CSI-2 module. See3CAM_CU40, a new member of e-con’s See3CAM family of UVC ...
(Date:10/13/2015)... ... October 13, 2015 , ... A child without a healthy ... SmileCareClub , the leading remote invisible aligner system, has joined with Global Dental ... without it. For each aligner treatment plan purchased, SmileCareClub will donate one clinic visit ...
(Date:10/13/2015)... ... October 13, 2015 , ... Protein is essential to good health. ... bone, and blood. But how much protein does the average man need in order ... according to the October 2015 issue of Harvard Men's Health Watch . Most ...
(Date:10/13/2015)... ... October 13, 2015 , ... Nordic ... unique health needs of new moms. Postnatal Omega-3, which has been named ... utilizes Nordic Naturals’ exclusive, new, ultra-concentrated omega-3 oil. This breakthrough oil combines ...
Breaking Medicine News(10 mins):